Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches

Karin, 2002, NF-κB in cancer: From innocent bystander to major culprit, Nat. Rev. Cancer, 2, 301, 10.1038/nrc780

Sun, 2011, Non-canonical NF-κB signaling pathway, Cell Res., 21, 71, 10.1038/cr.2010.177

Hoffmann, 2002, The IκB-NF-κB signaling module: Temporal control and selective gene activation, Science, 298, 1241, 10.1126/science.1071914

Solan, 2002, Relb cellular regulation and transcriptional activity are regulated by p100, J. Biol. Chem., 277, 1405, 10.1074/jbc.M109619200

Oeckinghaus, A., and Ghosh, S. (2009). The NF-κB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol., 1.

Hayden, 2008, Shared principles in NF-κB signaling, Cell, 132, 344, 10.1016/j.cell.2008.01.020

Tak, 2001, NF-κB: A key role in inflammatory diseases, J. Clin. Investig., 107, 7, 10.1172/JCI11830

Nakajima, 2013, Bidirectional regulation of NF-κB by reactive oxygen species: A role of unfolded protein response, Free Radic. Biol. Med., 65, 162, 10.1016/j.freeradbiomed.2013.06.020

Baeuerle, 1994, Function and activation of NF-κB in the immune system, Annu. Rev. Immunol., 12, 141, 10.1146/annurev.iy.12.040194.001041

Westbrook, 2010, Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse models, Mutat. Res., 705, 40, 10.1016/j.mrrev.2010.03.001

Tilstra, 2011, NF-κB in aging and disease, Aging Dis., 2, 449

Vallabhapurapu, 2009, Regulation and function of NF-κB transcription factors in the immune system, Annu. Rev. Immunol., 27, 693, 10.1146/annurev.immunol.021908.132641

Sun, 2008, New insights into NF-κB regulation and function, Trends Immunol., 29, 469, 10.1016/j.it.2008.07.003

Perkins, 2007, Integrating cell-signalling pathways with NF-κB and IKK function, Nat. Rev. Mol. Cell Biol., 8, 49, 10.1038/nrm2083

Hayden, 2004, Signaling to NF-κB, Genes Dev., 18, 2195, 10.1101/gad.1228704

Karin, 2000, Phosphorylation meets ubiquitination: The control of NF-κB activity, Annu. Rev. Immunol., 18, 621, 10.1146/annurev.immunol.18.1.621

Senftleben, 2001, Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway, Science, 293, 1495, 10.1126/science.1062677

Guan, 2005, DNA binding of repressor nuclear factor-κB p50/p50 depends on phosphorylation of Ser337 by the protein kinase a catalytic subunit, J. Biol. Chem., 280, 9957, 10.1074/jbc.M412180200

Basak, 2007, A fourth IκB protein within the NF-κB signaling module, Cell, 128, 369, 10.1016/j.cell.2006.12.033

Lo, 2006, Coordination between NF-κB family members p50 and p52 is essential for mediating ltβr signals in the development and organization of secondary lymphoid tissues, Blood, 107, 1048, 10.1182/blood-2005-06-2452

May, 2000, Selective inhibition of NF-κB activation by a peptide that blocks the interaction of nemo with the IκB kinase complex, Science, 289, 1550, 10.1126/science.289.5484.1550

Karin, 2002, Nf-[κ]b at the crossroads of life and death, Nat. Immunol., 3, 221, 10.1038/ni0302-221

Karin, 2000, The IκB kinase (IKK) and NF-κB: Key elements of proinflammatory signalling, Semin. Immunol., 12, 85, 10.1006/smim.2000.0210

Hayden, 2006, NF-κB and the immune response, Oncogene, 25, 6758, 10.1038/sj.onc.1209943

Xiao, 2001, NF-κB-inducing kinase regulates the processing of NF-kB2 p100, Mol. Cell, 7, 401, 10.1016/S1097-2765(01)00187-3

Coope, 2002, Cd40 regulates the processing of NF-κB2 p100 to p52, EMBO J., 21, 5375, 10.1093/emboj/cdf542

Derudder, 2003, Relb/p50 dimers are differentially regulated by tumor necrosis factor-α and lymphotoxin-β receptor activation: Critical roles for p100, J. Biol. Chem., 278, 23278, 10.1074/jbc.M300106200

Rong, 2011, Protective effects of oleanolic acid on cerebral ischemic damage in vivo and H2O2-induced injury in vitro, Pharm. Biol., 49, 78, 10.3109/13880209.2010.499130

Claudio, 2002, Baff-induced nemo-independent processing of NF-κB2 in maturing b cells, Nat. Immunol., 3, 958, 10.1038/ni842

Novack, 2003, The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis, J. Exp. Med., 198, 771, 10.1084/jem.20030116

Bonizzi, 2004, Activation of IKKα target genes depends on recognition of specific κB binding sites by relb:p52 dimers, EMBO J., 23, 4202, 10.1038/sj.emboj.7600391

Basak, 2008, Generation and activation of multiple dimeric transcription factors within the NF-κB signaling system, Mol. Cell. Biol., 28, 3139, 10.1128/MCB.01469-07

Jost, 2007, Aberrant NF-κB signaling in lymphoma: Mechanisms, consequences, and therapeutic implications, Blood, 109, 2700, 10.1182/blood-2006-07-025809

Hayden, 2011, Nf-κB in immunobiology, Cell Res., 21, 223, 10.1038/cr.2011.13

Sen, R., and Baltimore, D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 46, 705–716.

Nelson, 2004, Oscillations in NF-κB signaling control the dynamics of gene expression, Science, 306, 704, 10.1126/science.1099962

Prasad, 2010, NF-κB and cancer: How intimate is this relationship, Mol. Cell. Biochem., 336, 25, 10.1007/s11010-009-0267-2

Gupta, 2010, Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals, Cancer Metastasis Rev., 29, 405, 10.1007/s10555-010-9235-2

Karin, 2011, Inflammation meets cancer, with NF-κB as the matchmaker, Nat. Immunol., 12, 715, 10.1038/ni.2060

Guttridge, 1999, NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin d1, Mol. Cell. Biol., 19, 5785, 10.1128/MCB.19.8.5785

Gatica, 2007, The transcription factor nuclear factor-κB and cancer, Clin. Oncol., 19, 154, 10.1016/j.clon.2006.11.013

Hinz, 1999, NF-κB function in growth control: Regulation of cyclin D1 expression and G(0)/G(1)-to-S-phase transition, Mol. Cell. Biol., 19, 2690, 10.1128/MCB.19.4.2690

Cao, 2001, IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development, Cell, 107, 763, 10.1016/S0092-8674(01)00599-2

Beg, 1996, An essential role for NF-κB in preventing TNF-α-induced cell death, Science, 274, 782, 10.1126/science.274.5288.782

Martin, 1996, Suppression of TNF-α-induced apoptosis by NF-κB, Science, 274, 787, 10.1126/science.274.5288.787

Lane, 2002, Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi’s sarcoma, J. Virol., 76, 11570, 10.1128/JVI.76.22.11570-11583.2002

Overall, 2002, Strategies for MMP inhibition in cancer: Innovations for the post-trial era, Nat. Rev. Cancer, 2, 657, 10.1038/nrc884

Bartok, 2010, Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis, Immunol. Rev., 233, 233, 10.1111/j.0105-2896.2009.00859.x

Pickup, 2014, The extracellular matrix modulates the hallmarks of cancer, EMBO Rep., 15, 1243, 10.15252/embr.201439246

Brown, 2008, NF-κB in carcinoma therapy and prevention, Expert Opin. Ther. Targets, 12, 1109, 10.1517/14728222.12.9.1109

Sovak, 1997, Aberrant nuclear factor-κB/rel expression and the pathogenesis of breast cancer, J. Clin. Investig., 100, 2952, 10.1172/JCI119848

Nakshatri, 1997, Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth, Mol. Cell. Biol., 17, 3629, 10.1128/MCB.17.7.3629

Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025

Gambhir, 2015, Nuclear factor κB role in inflammation associated gastrointestinal malignancies, World J. Gastroenterol., 21, 3174, 10.3748/wjg.v21.i11.3174

Lind, 2001, Nuclear factor-κB is upregulated in colorectal cancer, Surgery, 130, 363, 10.1067/msy.2001.116672

Liu, 2012, NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression, J. Biol. Chem., 287, 25530, 10.1074/jbc.M112.356279

Hunter, 2002, NF-κB family of transcription factors: Central regulators of innate and adaptive immune functions, Clin. Microbiol. Rev., 15, 414, 10.1128/CMR.15.3.414-429.2002

Wang, 2003, B-cell antigen-receptor signalling in lymphocyte development, Immunology, 110, 411, 10.1111/j.1365-2567.2003.01756.x

Koretzky, 2009, T cell activation, Annu. Rev. Immunol., 27, 591, 10.1146/annurev.immunol.021908.132706

Kortum, 2013, A PLC-γ1-independent, RasGRP1-ERK dependent pathway drives lymphoproliferative disease in LAT-Y136F mutant mice, J. Immunol., 190, 147, 10.4049/jimmunol.1201458

Moscat, 2003, NF-κB activation by protein kinase C isoforms and B-cell function, EMBO Rep., 4, 31, 10.1038/sj.embor.embor704

Monaco, 2004, Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis, Proc. Natl. Acad. Sci. USA, 101, 5634, 10.1073/pnas.0401060101

Lieb, 2010, Biomarkers of the osteoprotegerin pathway: Clinical correlates, subclinical disease, incident cardiovascular disease and mortality, Arterioscler. Thromb. Vasc. Biol., 30, 1849, 10.1161/ATVBAHA.109.199661

Song, 2009, The interaction of nuclear factor-κB and cytokines is associated with schizophrenia, Biol. Psychiatry, 65, 481, 10.1016/j.biopsych.2008.10.018

Hajishengallis, 2013, Endogenous modulators of inflammatory cell recruitment, Trends Immunol., 34, 1, 10.1016/j.it.2012.08.003

Vidal, 2013, The role of “anti-inflammatory” cytokines in axon regeneration, Cytokine Growth Factor Rev., 24, 1, 10.1016/j.cytogfr.2012.08.008

Vlahopoulos, 2015, Dynamic aberrant NF-κB spurs tumorigenesis: A new model encompassing the microenvironment, Cytokine Growth Factor Rev., 26, 389, 10.1016/j.cytogfr.2015.06.001

Grivennikov, 2010, Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer, Cytokine Growth Factor Rev., 21, 11, 10.1016/j.cytogfr.2009.11.005

Bonavita, 2015, Phagocytes as Corrupted Policemen in Cancer-Related Inflammation, Adv. Cancer Res., 128, 141, 10.1016/bs.acr.2015.04.013

Mecollari, V., Nieuwenhuis, B., and Verhaagen, J. (2014). A perspective on the role of class III semaphorin signaling in central nervous system trauma. Front. Cell. Neurosci., 8.

Tanabe, K., Matsushima-Nishiwaki, R., Yamaguchi, S., Iida, H., Dohi, S., and Kozawa, O. (2010). Mechanisms of tumor necrosis factor-α-induced interleukin-6 synthesis in glioma cells. J. Neuroinflamm., 7.

Nakshatri, 2004, Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of C-jun N-terminal kinase, Oncogene, 23, 7330, 10.1038/sj.onc.1207995

Yamaguchi, 2011, Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation, Int. J. Mol. Med., 28, 1049

Butturini, 2014, Costunolide and dehydrocostuslactone, two natural sesquiterpene lactones, ameliorate the inflammatory process associated to experimental pleurisy in mice, Eur. J. Pharmacol., 730, 107, 10.1016/j.ejphar.2014.02.031

Whipple, R.A., Vitolo, M.I., Boggs, A.E., Charpentier, M.S., Thompson, K., and Martin, S.S. (2013). Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition. Breast Cancer Res., 15.

Karki, 2013, Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-κB activation in vascular smooth muscle cells, Biochim. Biophys. Acta Gen. Subj., 1830, 2619, 10.1016/j.bbagen.2012.12.015

Wang, 2010, Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/AkT/caspase and Fas-L/NF-κB signaling pathways and augmented by ubiquitin-proteasome inhibition, Toxicol. In Vitro, 24, 898, 10.1016/j.tiv.2009.11.019

Zang, 2012, Nitric oxide augments oridonin-induced efferocytosis by human histocytic lymphoma U937 cells via autophagy and the NF-κB-COX-2-IL-1β pathway, Free Radic. Res., 46, 1207, 10.3109/10715762.2012.700515

Wei, 2013, Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion, Apoptosis, 18, 1060, 10.1007/s10495-013-0854-2

Jia, 2013, Sesquiterpene lactones and their derivatives inhibit high glucose-induced NF-κB activation and MCP-1 and TGF-β1 expression in rat mesangial cells, Molecules, 18, 13061, 10.3390/molecules181013061

Koh, 2011, Inhibitory effects of casticin on migration of eosinophil and expression of chemokines and adhesion molecules in A549 lung epithelial cells via NF-κB inactivation, J. Ethnopharmacol., 136, 399, 10.1016/j.jep.2011.01.014

Li, 2009, Pseudolaric acid b suppresses T lymphocyte activation through inhibition of NF-κB signaling pathway and p38 phosphorylation, J. Cell. Biochem., 108, 87, 10.1002/jcb.22230

Lee, 2007, Inhibitory effect of eupatilin and jaceosidin isolated from artemisia princeps in IgE-induced hypersensitivity, Int. Immunopharmacol., 7, 1678, 10.1016/j.intimp.2007.08.028

Sen, 1996, Involvement of intracellular Ca2+ in oxidant-induced NF-κB activation, FEBS Lett., 385, 58, 10.1016/0014-5793(96)00346-8

Beyaert, 1993, Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF, EMBO J., 12, 3095, 10.1002/j.1460-2075.1993.tb05978.x

Manna, 1998, Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1, J. Biol. Chem., 273, 13245, 10.1074/jbc.273.21.13245

Natarajan, 1996, Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB, Proc. Natl. Acad. Sci. USA, 93, 9090, 10.1073/pnas.93.17.9090

Singh, 1995, Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κB, J. Biol. Chem., 270, 10631, 10.1074/jbc.270.18.10631

Kopp, 1994, Inhibition of NF-κB by sodium salicylate and aspirin, Science, 265, 956, 10.1126/science.8052854

Takada, 2004, Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation, Oncogene, 23, 9247, 10.1038/sj.onc.1208169

Grilli, 1996, Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation, Science, 274, 1383, 10.1126/science.274.5291.1383

Palayoor, 1998, Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells, Clin. Cancer Res., 4, 763

Ettarh, 2010, Nsaids and cell proliferation in colorectal cancer, Pharmaceuticals, 3, 2007, 10.3390/ph3072007

Blobaum, 2007, Structural and functional basis of cyclooxygenase inhibition, J. Med. Chem., 50, 1425, 10.1021/jm0613166

Zarghi, 2011, Selective COX-2 inhibitors: A review of their structure-activity relationships, Iran. J. Pharm. Res., 10, 655

Paikin, 2012, Aspirin, Circulation, 125, e439, 10.1161/CIRCULATIONAHA.111.046243

Drew, 2016, Aspirin and colorectal cancer: The promise of precision chemoprevention, Nat. Rev. Cancer, 16, 173, 10.1038/nrc.2016.4

Ittaman, 2014, The role of aspirin in the prevention of cardiovascular disease, Clin. Med. Res., 12, 147, 10.3121/cmr.2013.1197

Gupta, 2010, Inhibiting NF-κB activation by small molecules as a therapeutic strategy, Biochim. Biophys. Acta, 1799, 775, 10.1016/j.bbagrm.2010.05.004

Yin, 1998, The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-B, Nature, 396, 77, 10.1038/23948

Dikshit, 2006, Aspirin induces apoptosis through the inhibition of proteasome function, J. Biol. Chem., 281, 29228, 10.1074/jbc.M602629200

Yuan, 2001, Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ, Science, 293, 1673, 10.1126/science.1061620

Li, 2004, C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases, Med. Hypotheses, 62, 499, 10.1016/j.mehy.2003.12.014

Haegeman, 2006, Cross-talk between nuclear receptors and NF-κB, Oncogene, 25, 6868, 10.1038/sj.onc.1209935

Kalaitzidis, 2005, Transcription factor cross-talk: The estrogen receptor and NF-κB, Trends Endocrinol. Metab., 16, 46, 10.1016/j.tem.2005.01.004

Olivier, 2006, Raloxifene-induced myeloma cell apoptosis: A study of NF-κB inhibition and gene expression signature, Mol. Pharmacol., 69, 1615, 10.1124/mol.105.020479

Frantz, 1994, Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB, EMBO J., 13, 861, 10.1002/j.1460-2075.1994.tb06329.x

Meyer, 1997, Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation, FEBS Lett., 413, 354, 10.1016/S0014-5793(97)00930-7

McCaffrey, 1994, Cyclosporin A sensitivity of the NF-κB site of the IL2R alpha promoter in untransformed murine T cells, Nucleic Acids Res., 22, 2134, 10.1093/nar/22.11.2134

Sen, 1995, Expression and induction of nuclear factor-κB-related proteins in thymocytes, J. Immunol., 154, 3213, 10.4049/jimmunol.154.7.3213

Hirano, 2003, Inhibition of TNF-α-induced rantes expression in human hepatocyte-derived cells by fibrates, the hypolipidemic drugs, Int. Immunopharmacol., 3, 225, 10.1016/S1567-5769(02)00275-8

Wolf, 2005, The kinase inhibitor imatinib mesylate inhibits TNF-α production in vitro and prevents TNF-dependent acute hepatic inflammation, Proc. Natl. Acad. Sci. USA, 102, 13622, 10.1073/pnas.0501758102

Lawrence, 2004, Rapamycin suppresses experimental aortic aneurysm growth, J. Vasc. Surg., 40, 334, 10.1016/j.jvs.2004.05.020

Acarin, 2000, Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-κB in the postnatal rat brain, Neurosci. Lett., 288, 41, 10.1016/S0304-3940(00)01202-7

Ruan, 2003, Troglitazone antagonizes tumor necrosis factor-α-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-κB, J. Biol. Chem., 278, 28181, 10.1074/jbc.M303141200